StockNews.com started coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Performance Shares of BLCM opened at $0.14 on Wednesday. The company’s fifty day moving average is $0.17 and its 200-day moving average is […]
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report report published on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Performance NASDAQ BLCM opened at $0.23 on Friday. Bellicum Pharmaceuticals has a fifty-two week low of $0.06 and a fifty-two […]
StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report published on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 9.1 % Shares of NASDAQ:BLCM opened at $0.25 on Friday. The business has a fifty day simple moving average of $0.39 […]
StockNews com Initiates Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, LADENBURG THALM/SH SH cut shares of Bellicum Pharmaceuticals from a buy rating to a neutral rating in a research report on […]